Cannabidiol and other non-psychoactive cannabinoids for prevention and treatment of gastrointestinal disorders: useful nutraceuticals?

V Martínez, A Iriondo De-Hond, F Borrelli… - International Journal of …, 2020 - mdpi.com
Cannabis sativa is an aromatic annual flowering plant with several botanical varieties, used
for different purposes, like the production of fibers, the production of oil from the seeds, and …

Reviewing the role of the endocannabinoid system in the pathophysiology of depression

I Gallego-Landin, A Garcia-Baos… - Frontiers in …, 2021 - frontiersin.org
Major depressive disorder is a high-impact, debilitating disease and it is currently
considered the most prevalent mental illness. It is associated with disability, as well as …

The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders

GS Malhi, E Bell, D Bassett, P Boyce… - Australian & New …, 2021 - journals.sagepub.com
Objectives: To provide advice and guidance regarding the management of mood disorders,
derived from scientific evidence and supplemented by expert clinical consensus to formulate …

Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled trial

J Vela, L Dreyer, KK Petersen, L Arendt-Nielsen… - Pain, 2022 - journals.lww.com
Cannabidiol (CBD) is increasingly used as analgesic medication although the recent
International Association for the Study of Pain Presidential Task Force on cannabis and …

Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids

TS Reddy, R Zomer, N Mantri - Phytotherapy Research, 2023 - Wiley Online Library
Medical cannabis has received significant interest in recent years due to its promising
benefits in the management of pain, anxiety, depression and neurological and movement …

A scoping review of the use of cannabidiol in psychiatric disorders

AE Kirkland, MC Fadus, SA Gruber, KM Gray… - Psychiatry …, 2022 - Elsevier
Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and
clinicians are challenged with understanding the implications of CBD for treating mental …

Potential role of cannabidiol on sports recovery: a narrative review

D Rojas-Valverde - Frontiers in physiology, 2021 - frontiersin.org
The use of cannabidiol (CBD) among athletes is becoming extensive and frequent. This
could be due to the elimination of CBD from the list of prohibited substances by federations …

Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials

KA McKee, A Hmidan, CE Crocker, RW Lam… - Journal of Psychiatric …, 2021 - Elsevier
The utility of cannabinoids and cannabinoid-based products (CBPs) as a pharmacological
aid to treat psychiatric disorders in adulthood is still poorly understood despite a number of …

Clinical staging for youth mental disorders: Progress in reforming diagnosis and clinical care

PD McGorry, C Mei - Annual Review of Developmental …, 2021 - annualreviews.org
Current silo-based diagnostic systems for mental disorders lack utility and fail to fulfil a
fundamental purpose of diagnosis: to guide treatment planning and predict outcomes …

New pharmacologic approaches to the treatment of bipolar depression

K Keramatian, T Chakrabarty, A DuBow, G Saraf… - Drugs, 2023 - Springer
Depression is the most commonly experienced mood state over the life span in individuals
with bipolar disorder (BD) and is the primary driver of functional impairment and suicidality in …